Anti-Human CD20 Recombinant Antibody(Ofatumumab)

Product Information

Catalog Number	YR1129
Product Name	Anti-Human CD20 Recombinant Antibody(Ofatumumab)
Molecular Name	Ofatumumab
Alias	Anti-CD20 Recombinant Antibody, Research Grade Ofatumumab
CAS Number	679818-59-8
Molecular Weight	149 kDa
Target	CD20[Homo sapiens]
Isotype	IgG1 Kappa
Clonity	Monoclonal
Source	CHO Cells
Size	1mg, 5mg
Concentration	1mg/ml
Purity	>95% as determined by SDS-PAGE
Buffer	PBS, pH7.5
Background	Ofatumumab, sold under the brand name Arzerra among others, is a fully human monoclonal antibody to CD20, which appears to inhibit early-stage B lymphocyte activation. It is FDA approved for treating chronic lymphocytic leukemia that is refractory to fludarabine and alemtuzumab (Campath) and for the treatment of multiple sclerosis.
Storage	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Note	This product is for research use only.

Cat#	Product Name	Species	Host	Applications	Size	Price